標的放射線治療薬のグローバル市場展望 2023年-2029年：放射性ヨウ素治療薬、放射性抗体治療薬、その他

■ 英語タイトル：Targeted Radiotherapy Drug Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14484）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14484
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[標的放射線治療薬のグローバル市場展望 2023年-2029年：放射性ヨウ素治療薬、放射性抗体治療薬、その他]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の標的放射線治療薬市場規模と予測を収録しています。・世界の標的放射線治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の標的放射線治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の標的放射線治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「放射性ヨウ素治療薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

標的放射線治療薬のグローバル主要企業は、Novartis、 Bayer、 Endocyte、 Progenics Pharmaceuticals、 Jubilant Radiopharma、 Curium、 Fermi Energia、 Nucleus RadioPharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、標的放射線治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の標的放射線治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の標的放射線治療薬市場：タイプ別市場シェア、2022年
・放射性ヨウ素治療薬、放射性抗体治療薬、その他

世界の標的放射線治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の標的放射線治療薬市場：用途別市場シェア、2022年
・総合病院、専門病院

世界の標的放射線治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の標的放射線治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における標的放射線治療薬のグローバル売上、2018年-2023年
・主要企業における標的放射線治療薬のグローバル売上シェア、2022年
・主要企業における標的放射線治療薬のグローバル販売量、2018年-2023年
・主要企業における標的放射線治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis、 Bayer、 Endocyte、 Progenics Pharmaceuticals、 Jubilant Radiopharma、 Curium、 Fermi Energia、 Nucleus RadioPharma

*************************************************************

・調査・分析レポートの概要
標的放射線治療薬市場の定義
市場セグメント
世界の標的放射線治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の標的放射線治療薬市場規模
世界の標的放射線治療薬市場規模：2022年 VS 2029年
世界の標的放射線治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの標的放射線治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の標的放射線治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：放射性ヨウ素治療薬、放射性抗体治療薬、その他
標的放射線治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：総合病院、専門病院
標的放射線治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別標的放射線治療薬市場規模 2022年と2029年
地域別標的放射線治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Bayer、 Endocyte、 Progenics Pharmaceuticals、 Jubilant Radiopharma、 Curium、 Fermi Energia、 Nucleus RadioPharma
...

This research report provides a comprehensive analysis of the Targeted Radiotherapy Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Targeted Radiotherapy Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Targeted Radiotherapy Drug, challenges faced by the industry, and potential opportunities for market players.
The global Targeted Radiotherapy Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Targeted Radiotherapy Drug market presents opportunities for various stakeholders, including General Hospital, Specialty Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Targeted Radiotherapy Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Targeted Radiotherapy Drug market was valued at US$ 5569.5 million in 2022 and is projected to reach US$ 8401.7 million by 2029, at a CAGR of 6.1% during the forecast period.
Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.
Key Features:
The research report on the Targeted Radiotherapy Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Targeted Radiotherapy Drug market.
Market Overview: The report provides a comprehensive overview of the Targeted Radiotherapy Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Targeted Radiotherapy Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Targeted Radiotherapy Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Targeted Radiotherapy Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Targeted Radiotherapy Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Targeted Radiotherapy Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Targeted Radiotherapy Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Targeted Radiotherapy Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Targeted Radiotherapy Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Targeted Radiotherapy Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Radioactive Iodine Therapeutic Drugs
Radioactive Antibody Therapeutic Drugs
Others
Market segment by Application
General Hospital
Specialty Hospital
Global Targeted Radiotherapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Bayer
Endocyte
Progenics Pharmaceuticals
Jubilant Radiopharma
Curium
Fermi Energia
Nucleus RadioPharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Radiotherapy Drug, market overview.
Chapter 2: Global Targeted Radiotherapy Drug market size in revenue.
Chapter 3: Detailed analysis of Targeted Radiotherapy Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Radiotherapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Targeted Radiotherapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Radiotherapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Radiotherapy Drug Overall Market Size
2.1 Global Targeted Radiotherapy Drug Market Size: 2022 VS 2029
2.2 Global Targeted Radiotherapy Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Radiotherapy Drug Players in Global Market
3.2 Top Global Targeted Radiotherapy Drug Companies Ranked by Revenue
3.3 Global Targeted Radiotherapy Drug Revenue by Companies
3.4 Top 3 and Top 5 Targeted Radiotherapy Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Radiotherapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Radiotherapy Drug Players in Global Market
3.6.1 List of Global Tier 1 Targeted Radiotherapy Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Radiotherapy Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Targeted Radiotherapy Drug Market Size Markets, 2022 & 2029
4.1.2 Radioactive Iodine Therapeutic Drugs
4.1.3 Radioactive Antibody Therapeutic Drugs
4.1.4 Others
4.2 By Type – Global Targeted Radiotherapy Drug Revenue & Forecasts
4.2.1 By Type – Global Targeted Radiotherapy Drug Revenue, 2018-2023
4.2.2 By Type – Global Targeted Radiotherapy Drug Revenue, 2024-2029
4.2.3 By Type – Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Targeted Radiotherapy Drug Market Size, 2022 & 2029
5.1.2 General Hospital
5.1.3 Specialty Hospital
5.2 By Application – Global Targeted Radiotherapy Drug Revenue & Forecasts
5.2.1 By Application – Global Targeted Radiotherapy Drug Revenue, 2018-2023
5.2.2 By Application – Global Targeted Radiotherapy Drug Revenue, 2024-2029
5.2.3 By Application – Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Targeted Radiotherapy Drug Market Size, 2022 & 2029
6.2 By Region – Global Targeted Radiotherapy Drug Revenue & Forecasts
6.2.1 By Region – Global Targeted Radiotherapy Drug Revenue, 2018-2023
6.2.2 By Region – Global Targeted Radiotherapy Drug Revenue, 2024-2029
6.2.3 By Region – Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Targeted Radiotherapy Drug Revenue, 2018-2029
6.3.2 US Targeted Radiotherapy Drug Market Size, 2018-2029
6.3.3 Canada Targeted Radiotherapy Drug Market Size, 2018-2029
6.3.4 Mexico Targeted Radiotherapy Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Targeted Radiotherapy Drug Revenue, 2018-2029
6.4.2 Germany Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.3 France Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.4 U.K. Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.5 Italy Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.6 Russia Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.7 Nordic Countries Targeted Radiotherapy Drug Market Size, 2018-2029
6.4.8 Benelux Targeted Radiotherapy Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Targeted Radiotherapy Drug Revenue, 2018-2029
6.5.2 China Targeted Radiotherapy Drug Market Size, 2018-2029
6.5.3 Japan Targeted Radiotherapy Drug Market Size, 2018-2029
6.5.4 South Korea Targeted Radiotherapy Drug Market Size, 2018-2029
6.5.5 Southeast Asia Targeted Radiotherapy Drug Market Size, 2018-2029
6.5.6 India Targeted Radiotherapy Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Targeted Radiotherapy Drug Revenue, 2018-2029
6.6.2 Brazil Targeted Radiotherapy Drug Market Size, 2018-2029
6.6.3 Argentina Targeted Radiotherapy Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Targeted Radiotherapy Drug Revenue, 2018-2029
6.7.2 Turkey Targeted Radiotherapy Drug Market Size, 2018-2029
6.7.3 Israel Targeted Radiotherapy Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Targeted Radiotherapy Drug Market Size, 2018-2029
6.7.5 UAE Targeted Radiotherapy Drug Market Size, 2018-2029
7 Targeted Radiotherapy Drug Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Targeted Radiotherapy Drug Major Product Offerings
7.1.4 Novartis Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Targeted Radiotherapy Drug Major Product Offerings
7.2.4 Bayer Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Endocyte
7.3.1 Endocyte Company Summary
7.3.2 Endocyte Business Overview
7.3.3 Endocyte Targeted Radiotherapy Drug Major Product Offerings
7.3.4 Endocyte Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.3.5 Endocyte Key News & Latest Developments
7.4 Progenics Pharmaceuticals
7.4.1 Progenics Pharmaceuticals Company Summary
7.4.2 Progenics Pharmaceuticals Business Overview
7.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Major Product Offerings
7.4.4 Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.4.5 Progenics Pharmaceuticals Key News & Latest Developments
7.5 Jubilant Radiopharma
7.5.1 Jubilant Radiopharma Company Summary
7.5.2 Jubilant Radiopharma Business Overview
7.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Major Product Offerings
7.5.4 Jubilant Radiopharma Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.5.5 Jubilant Radiopharma Key News & Latest Developments
7.6 Curium
7.6.1 Curium Company Summary
7.6.2 Curium Business Overview
7.6.3 Curium Targeted Radiotherapy Drug Major Product Offerings
7.6.4 Curium Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.6.5 Curium Key News & Latest Developments
7.7 Fermi Energia
7.7.1 Fermi Energia Company Summary
7.7.2 Fermi Energia Business Overview
7.7.3 Fermi Energia Targeted Radiotherapy Drug Major Product Offerings
7.7.4 Fermi Energia Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.7.5 Fermi Energia Key News & Latest Developments
7.8 Nucleus RadioPharma
7.8.1 Nucleus RadioPharma Company Summary
7.8.2 Nucleus RadioPharma Business Overview
7.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Major Product Offerings
7.8.4 Nucleus RadioPharma Targeted Radiotherapy Drug Revenue in Global Market (2018-2023)
7.8.5 Nucleus RadioPharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Targeted Radiotherapy Drug Market Opportunities & Trends in Global Market
Table 2. Targeted Radiotherapy Drug Market Drivers in Global Market
Table 3. Targeted Radiotherapy Drug Market Restraints in Global Market
Table 4. Key Players of Targeted Radiotherapy Drug in Global Market
Table 5. Top Targeted Radiotherapy Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Targeted Radiotherapy Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Targeted Radiotherapy Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Targeted Radiotherapy Drug Product Type
Table 9. List of Global Tier 1 Targeted Radiotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Radiotherapy Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Targeted Radiotherapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Targeted Radiotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Targeted Radiotherapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Targeted Radiotherapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Targeted Radiotherapy Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Targeted Radiotherapy Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Targeted Radiotherapy Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Targeted Radiotherapy Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Targeted Radiotherapy Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Targeted Radiotherapy Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Targeted Radiotherapy Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Targeted Radiotherapy Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Targeted Radiotherapy Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Targeted Radiotherapy Drug Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Targeted Radiotherapy Drug Product Offerings
Table 32. Novartis Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Targeted Radiotherapy Drug Product Offerings
Table 36. Bayer Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Endocyte Company Summary
Table 39. Endocyte Targeted Radiotherapy Drug Product Offerings
Table 40. Endocyte Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Endocyte Key News & Latest Developments
Table 42. Progenics Pharmaceuticals Company Summary
Table 43. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product Offerings
Table 44. Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Progenics Pharmaceuticals Key News & Latest Developments
Table 46. Jubilant Radiopharma Company Summary
Table 47. Jubilant Radiopharma Targeted Radiotherapy Drug Product Offerings
Table 48. Jubilant Radiopharma Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Jubilant Radiopharma Key News & Latest Developments
Table 50. Curium Company Summary
Table 51. Curium Targeted Radiotherapy Drug Product Offerings
Table 52. Curium Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Curium Key News & Latest Developments
Table 54. Fermi Energia Company Summary
Table 55. Fermi Energia Targeted Radiotherapy Drug Product Offerings
Table 56. Fermi Energia Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Fermi Energia Key News & Latest Developments
Table 58. Nucleus RadioPharma Company Summary
Table 59. Nucleus RadioPharma Targeted Radiotherapy Drug Product Offerings
Table 60. Nucleus RadioPharma Targeted Radiotherapy Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Nucleus RadioPharma Key News & Latest Developments
List of Figures
Figure 1. Targeted Radiotherapy Drug Segment by Type in 2022
Figure 2. Targeted Radiotherapy Drug Segment by Application in 2022
Figure 3. Global Targeted Radiotherapy Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Targeted Radiotherapy Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Targeted Radiotherapy Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Radiotherapy Drug Revenue in 2022
Figure 8. By Type - Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Targeted Radiotherapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Targeted Radiotherapy Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 16. US Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 20. Germany Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 28. China Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Targeted Radiotherapy Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Targeted Radiotherapy Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Endocyte Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Jubilant Radiopharma Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Curium Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Fermi Energia Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nucleus RadioPharma Targeted Radiotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

標的放射線治療薬のグローバル市場展望 2023年-2029年：放射性ヨウ素治療薬、放射性抗体治療薬、その他

グローバル市場調査会社